Jeffrey C. Lightcap - 07 May 2021 Form 4/A - Amendment Insider Report for SURGALIGN HOLDINGS, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4/A - Amendment
Accepted by SEC
02 Jul 2021, 16:24:49 UTC
Original report date
10 May 2021
Next SEC filing
21 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By Jessica Rumschlag as attorney in fact

Key filing fact

Jeffrey C. Lightcap filed Form 4/A - Amendment for SURGALIGN HOLDINGS, INC. on 02 Jul 2021.

Key facts

  • This page summarizes Jeffrey C. Lightcap's Form 4/A - Amendment filing for SURGALIGN HOLDINGS, INC..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2021, 16:24.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRGA transaction

Common Stock

Award

Transaction value
$0
Shares
+72,254
Change %
+19%
Price
$0.000000
Shares after
449,649
Date
07 May 2021
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Form 4 filed on 5/10/2021 representing restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant erroneously reported 57,803 RSUs in column four. The purpose of this amendment is to correct the total underlying shares in columns four and five.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .